M&A Deal Summary |
|
|---|---|
| Date | 2010-11-29 |
| Target | Excelitas Technologies |
| Sector | Technology Hardware |
| Buyer(s) | Veritas Capital |
| Sellers(s) | Revvity |
| Deal Type | Divestiture |
| Deal Value | 500M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 1992 |
| PE ASSETS | 40.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Veritas Capital is a private equity investment firm that targets investments in defense, aerospace, government services, media/telecommunications, consumer products, and specialty manufacturing companies. Veritas generally partners with management when pursuing investments. Prospective transaction situations include buyouts, growth capital investments, and leveraged recapitalizations. Veritas Capital was established in 1992 and is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 11 of 40 |
| Sector (Technology Hardware) | 1 of 3 |
| Type (Divestiture) | 4 of 18 |
| State (Massachusetts) | 1 of 4 |
| Country (United States) | 11 of 38 |
| Year (2010) | 3 of 3 |
| Size (of disclosed) | 18 of 22 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-10-13 |
Perspecta
Chantilly, Virginia, United States Perspecta, Inc. is a provider of high impact, analytical and technical expertise in the areas of data analytics, system engineering, and integration and cyber security for the U.S. Government and commercial customers. Perspecta is based in Chantilly, Virginia. |
Buy | $815M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-09-30 |
Vangent
Arlington, Virginia, United States Vangent, Inc. is a premier provider of Consulting, Systems Integration, Human Capital Management and Business Process Outsourcing services to the U.S. federal and international governments, higher education institutions, student financial aid entities and corporations. |
Sell | $960M |
| Category | Company |
|---|---|
| Founded | 1937 |
| Sector | Medical Products |
| Employees | 11,000 |
| Revenue | 3.3B USD (2022) |
Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity was formerly known as PerkinElmer. The Company was formed in 1937 and is based in Waltham, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 11 |
| Sector (Technology Hardware) | 1 of 1 |
| Type (Divestiture) | 7 of 11 |
| State (Massachusetts) | 2 of 4 |
| Country (United States) | 7 of 11 |
| Year (2010) | 1 of 1 |
| Size (of disclosed) | 2 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-08-03 |
VisEn Medical
Bedford, Massachusetts, United States VisEn’s in vivo fluorescence imaging technologies, including its Fluorescence Agent Portfolio and its Fluorescence Molecular Tomographic (FMTTM) Imaging Systems provide robust fluorescence molecular imaging performance in identifying, characterizing and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-02-14 |
Chemagen Biopolymer-Technologie AG
Baesweiler, Germany chemagen Biopolymer-Technologie AG, a key player in the field of automated nucleic acid isolation, as part of the Company’s strategy to advance its offerings to the molecular diagnostics and research markets. |
Buy | - |
